1. Home
  2. TVTX vs LION Comparison

TVTX vs LION Comparison

Compare TVTX & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$45.81

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$13.40

Market Cap

3.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TVTX
LION
Founded
N/A
1997
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.5B
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
TVTX
LION
Price
$45.81
$13.40
Analyst Decision
Strong Buy
Buy
Analyst Count
13
9
Target Price
$40.62
$11.89
AVG Volume (30 Days)
2.0M
3.7M
Earning Date
05-04-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
92.89
N/A
EPS
N/A
N/A
Revenue
N/A
$2,631,800,000.00
Revenue This Year
$44.76
N/A
Revenue Next Year
$35.51
$22.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.88
$5.65
52 Week High
$48.61
$15.01

Technical Indicators

Market Signals
Indicator
TVTX
LION
Relative Strength Index (RSI) 58.73 57.81
Support Level $41.43 $11.88
Resistance Level $48.60 $15.01
Average True Range (ATR) 2.02 0.60
MACD -0.24 -0.09
Stochastic Oscillator 65.70 49.55

Price Performance

Historical Comparison
TVTX
LION

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

Share on Social Networks: